A Randomized, Open Label, Two-Arm, Cross-Over Design Study to Compare the Pharmacodynamics and Pharmacokinetics of Insulin Glulisine and Insulin Lispro in Obese Patients With Type 2 Diabetes.

Trial Profile

A Randomized, Open Label, Two-Arm, Cross-Over Design Study to Compare the Pharmacodynamics and Pharmacokinetics of Insulin Glulisine and Insulin Lispro in Obese Patients With Type 2 Diabetes.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Sep 2009

At a glance

  • Drugs Insulin glulisine; Insulin lispro
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 22 Sep 2009 Actual initiation date (Nov 2004) added as reported by ClinicalTrials.gov.
    • 12 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top